{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:54:00Z","timestamp":1775141640118,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"vor","delay-in-days":300,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Brasileira de Reumatologia"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.rbr.2013.04.003","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T13:24:08Z","timestamp":1396358648000},"page":"483-493","source":"Crossref","is-referenced-by-count":21,"title":["Adapta\u00e7\u00e3o transcultural do \u201cEULAR Sj\u00f6gren's Syndrome Disease Activity Index (ESSDAI)\u201d para a l\u00edngua portuguesa"],"prefix":"10.1186","volume":"53","author":[{"given":"\u00c9rica Vieira","family":"Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira Tatiyama","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Alto\u00e9","family":"Giovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio Aquino","family":"Paganotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e1gela Valad\u00e3o","family":"Cad\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"10.1016\/j.rbr.2013.04.003_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren's syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimm Rev."},{"issue":"1","key":"10.1016\/j.rbr.2013.04.003_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S0482-50042013000100003","article-title":"Preval\u00eancia de s\u00edndrome de Sj\u00f6gren em uma regi\u00e3o metropolitana do Brasil","volume":"53","author":"Valim","year":"2013","journal-title":"Rev Bras Reumatol."},{"issue":"4","key":"10.1016\/j.rbr.2013.04.003_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of Primary Sj\u00f6gren Syndrome: a Systematic Review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.rbr.2013.04.003_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semarthrit.2007.06.002","article-title":"Primary Sj\u00f6gren's syndrome: current and prospective therapies","volume":"37","author":"Thanou-Stavraki","year":"2008","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.rbr.2013.04.003_bib0025","series-title":"Health measurement scales: a practical guide to their development and use.","author":"Streiner","year":"2008"},{"issue":"1","key":"10.1016\/j.rbr.2013.04.003_bib0030","first-page":"143","article-title":"Outcome measures for Sj\u00f6gren's syndrome","volume":"32","author":"Pillemer","year":"2005","journal-title":"J Rheumatol."},{"issue":"10","key":"10.1016\/j.rbr.2013.04.003_bib0035","first-page":"1180","article-title":"Revisiting Sj\u00f6gren's syndrome in the new millennium: perspectives on assessment and outcome measures","volume":"40","author":"Bowman","year":"2001","journal-title":"Report from a workshop held on 23rd March 2000, at Oxford UK. Rheumatology (Oxford)."},{"issue":"9","key":"10.1016\/j.rbr.2013.04.003_bib0040","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sj\u00f6gren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.rbr.2013.04.003_bib0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sj\u00f6gren's syndrome. after two infusions of rituximab (anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.rbr.2013.04.003_bib0050","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren's syndrome with rituximab: results of a randomized, double-blind, placebo- controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis."},{"issue":"1\u20132","key":"10.1016\/j.rbr.2013.04.003_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2012.01.013","article-title":"Outcome measures for primary Sj\u00f6gren's syndrome","volume":"39","author":"Seror","year":"2012","journal-title":"J Autoimmun."},{"issue":"2","key":"10.1016\/j.rbr.2013.04.003_bib0060","first-page":"208","article-title":"Rituximab in central nervous system manifestations of patients with primary Sj\u00f6gren's syndrome: results from the AIR registry","volume":"30","author":"Mekinian","year":"2012","journal-title":"Clin Exp Rheumatol."},{"issue":"4","key":"10.1016\/j.rbr.2013.04.003_bib0065","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rbr.2013.04.003_bib0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","article-title":"Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: its effect on salivary and serum inflammatory markers","volume":"58","author":"Tishle","year":"1999","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.rbr.2013.04.003_bib0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2013.04.003_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1008846618880","article-title":"A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach","volume":"7","author":"Herdman","year":"1998","journal-title":"Qual Life Res."},{"issue":"1","key":"10.1016\/j.rbr.2013.04.003_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0021-9681(85)90005-0","article-title":"A methodological framework for assessing health indices","volume":"38","author":"Kirshner","year":"1985","journal-title":"J Chron Dis."},{"issue":"12","key":"10.1016\/j.rbr.2013.04.003_bib0090","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/rheumatology\/kem280","article-title":"Sj\u00f6gren's Systemic Clinical Activity Index (SCAI): a systemic disease activity measure for use in clinical trials in primary Sj\u00f6gren's syndrome","volume":"46","author":"Bowman","year":"2007","journal-title":"Rheumatology (Oxford)."},{"issue":"7","key":"10.1016\/j.rbr.2013.04.003_bib0095","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/art.22658","article-title":"Sj\u00f6gren's Syndrome Disease Damage Index and Disease Activity Index: scoring systems for the assessment of disease damage and disease activity in Sj\u00f6gren's syndrome, derived from an analysis of a cohort of Italian patients","volume":"56","author":"Vitali","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.rbr.2013.04.003_bib0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2362.2010.02303.x","article-title":"Primary Sj\u00f6gren's syndrome activity and damage indices comparison","volume":"40","author":"Campar","year":"2010","journal-title":"Eur J Clin Invest."},{"issue":"4","key":"10.1016\/j.rbr.2013.04.003_bib0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/acr.20173","article-title":"Accurate detection of changes in disease activity in primary Sj\u00f6gren's syndrome by the European League Against Rheumatism Sj\u00f6gren's Syndrome Disease Activity Index","volume":"62","author":"Seror","year":"2010","journal-title":"Arthritis Care Res."},{"issue":"8","key":"10.1016\/j.rbr.2013.04.003_bib0110","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/annrheumdis-2011-200460","article-title":"Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sj\u00f6gren's syndrome treated with rituximab","volume":"71","author":"Meiners","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.rbr.2013.04.003_bib0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0104-56872008000300012","article-title":"Tradu\u00e7\u00e3o e adapta\u00e7\u00e3o transcultural de instrumentos estrangeiros para o portugu\u00eas brasileiro","volume":"20","author":"Giusti","year":"2008","journal-title":"Pr\u00f3-Fono R Atual Cient."},{"key":"10.1016\/j.rbr.2013.04.003_bib0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2013.04.003_bib0125","series-title":"In: Multivariate data analysis.","author":"Hair","year":"1995"},{"issue":"Supl 1","key":"10.1016\/j.rbr.2013.04.003_bib0130","first-page":"67","article-title":"Adapta\u00e7\u00e3o transcultural e avalia\u00e7\u00e3o das. propriedades psicom\u00e9tricas do Sj\u00f6gren's Syndrome Disease Activity Index (SSDAI) para a l\u00edngua portuguesa brasileira","volume":"52","author":"Valim","year":"2012","journal-title":"Rev Bras Reumatol."},{"issue":"Supl 1","key":"10.1016\/j.rbr.2013.04.003_bib0135","first-page":"165","article-title":"Valim. V. Adapta\u00e7\u00e3o transcultural e avalia\u00e7\u00e3o das propriedades psicom\u00e9tricas do \u201cEULAR Sj\u00f6gren's Syndrome Clinical Activity Index\u201d (SCAI) para a l\u00edngua portuguesa brasileira","volume":"52","author":"Alto\u00e9","year":"2012","journal-title":"Rev Bras Reumatol."},{"key":"10.1016\/j.rbr.2013.04.003_bib0140","article-title":"Qualidade dos instrumentos epidemiol\u00f3gicos In: Epidemiologia: fundamentos, m\u00e9todos e aplica\u00e7\u00f5es","author":"Reichenheim","year":"2011","journal-title":"Almeida-Filho N, Barreto M. Rio de Janeiro: Guanabara-Koogan;"},{"issue":"Suppl 3","key":"10.1016\/j.rbr.2013.04.003_bib0145","first-page":"299","article-title":"Argentine validation of the EULAR. activity index: primary Sj\u00f6gren's syndrome","volume":"70","author":"Secco","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 3","key":"10.1016\/j.rbr.2013.04.003_bib0150","first-page":"510","article-title":"Relationship between disease activity of primary Sj\u00f6gren's syndrome and patient reported outcome \u2013 data from an interim analysis of the UK primary Sj\u00f6gren's syndrome registry","volume":"70","author":"Bowman","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 3","key":"10.1016\/j.rbr.2013.04.003_bib0155","first-page":"505","article-title":"Assessment of systemic disease activity is complementary to assessment of patient's symptoms in primary Sj\u00f6gren's syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 3","key":"10.1016\/j.rbr.2013.04.003_bib0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/annrheumdis-2012-eular.3154","article-title":"Correlation of clinical, serologic and histologic findings in a large cohort of primary Sj\u00f6gren's. syndrome patients: a multicentric cross-sectional study","volume":"71","author":"Baldini","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rbr.2013.04.003_bib0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/annrheumdis-2011-200766","article-title":"Clinical applicability of the EULAR Sj\u00f6gren's syndrome disease activity index: a. cumulative ESSDAI score adds in describing disease severity","volume":"71","author":"Risselada","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"Sup","key":"10.1016\/j.rbr.2013.04.003_bib0170","first-page":"8","article-title":"Primary Sj\u00f6gren's syndrome: diagnostic criteria, clinical features, and disease activity","volume":"24","author":"Manthorpe","year":"1997","journal-title":"J Rheumatol."},{"key":"10.1016\/j.rbr.2013.04.003_bib0175","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/ard.2011.153098","article-title":"Serum \u03b22 microglobulin correlates with the new ESSDAI in patients with Sj\u00f6gren's syndrome","volume":"70","author":"Pertovaara","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2013.04.003_bib0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/rheumatology\/keh509","article-title":"Flares of systemic disease in primary Sj\u00f6gren's syndrome","volume":"44","author":"Stevens","year":"2005","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"10.1016\/j.rbr.2013.04.003_bib0185","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI: a disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"The Committee on Prognosis Studies in SLE. Arthritis Rheum."},{"key":"10.1016\/j.rbr.2013.04.003_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/ard.2008.097758","article-title":"Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"68","author":"Merkel","year":"2009","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"10.1016\/j.rbr.2013.04.003_bib0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of. measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.rbr.2013.04.003_bib0200","first-page":"311","article-title":"Association of serum interferon-inducible chemokines with systemic disease activity","volume":"70","author":"Theander","year":"2011","journal-title":"BAFF and markers of B-cell activation in patients with primary Sj\u00f6gren's syndrome. Ann Rheum Dis."},{"issue":"Suppl3","key":"10.1016\/j.rbr.2013.04.003_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/annrheumdis-2012-eular.1749","article-title":"Efficacy of rituximab in systemic. manifestations of patients with primary Sj\u00f6gren's syndrome: results from the AIR registry","volume":"71","author":"Cinquetti","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"10.1016\/j.rbr.2013.04.003_bib0210","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sj\u00f6gren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren's syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.rbr.2013.04.003_bib0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/BOR.0b013e3283524c37","article-title":"How to assess treatment efficacy in Sj\u00f6gren's syndrome","volume":"24","author":"Vissink","year":"2012","journal-title":"Curr Opin Rheumatol."}],"container-title":["Revista Brasileira de Reumatologia"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0482500413000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0482500413000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T18:15:38Z","timestamp":1514916938000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0482500413000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0482500413000077"],"URL":"https:\/\/doi.org\/10.1016\/j.rbr.2013.04.003","relation":{},"ISSN":["0482-5004"],"issn-type":[{"value":"0482-5004","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}